|
|
|
|
Delaware
|
|
001-35706
|
|
16-1630142
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
1120 S. Capital of Texas Highway
Building 1, Suite #300
Austin, Texas 87846
(Address of principal executive offices) (Zip Code)
|
|
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Exhibit No.
|
|
Description of Document
|
16.1
|
|
Letter dated January 20, 2017 from Moss Adams LLP to the Securities and Exchange Commission.
|
|
|
|
|
|
|
|
APOLLO ENDOSURGERY, INC.
|
|
|
|
|
|
|
|
Dated: January 20, 2017
|
|
|
|
|
|
|
By:
|
/s/ Todd Newton
|
|
|
|
Name:
|
Todd Newton
|
|
|
|
Title:
|
Chief Executive Officer
|
|
Exhibit No.
|
|
Description of Document
|
16.1
|
|
Letter dated January 20, 2017 from Moss Adams LLP to the Securities and Exchange Commission.
|
1.
|
We are in agreement with the statements made in Item 4.01(a).
|
2.
|
We have no basis on which to agree or disagree with the statements made in paragraphs one through three of Item 4.01(b). We are in agreement with the statements made in paragraph four of Item 4.01(b).
|